Answers are grounded in this paper and cite their sources.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an indolent Hodgkin lymphoma (HL) entity counting for ∼5% of all HLs [1]. However, it seems to be a biologically distinct disease with a f...
No takes yet. Share an insight, caveat, or question.
Prusila et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: